EZR and cancer: Interestingly, consistent cancer cell killing response in all samples except HUSOV15 was achieved only when vIL-2 virus was added to the autologous TIL therapy in OvCa co-cultures compared to the TILs alone group (p < 0.05) (Fig. 2A–L).